Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Meritor (MTOR) Q2 Earnings Top Estimates

12:05pm, Thursday, 30'th Apr 2020
Meritor (MTOR) delivered earnings and revenue surprises of 37.04% and -2.11%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Meritor (MTOR) Q2 Earnings Top Estimates

12:05pm, Thursday, 30'th Apr 2020
Meritor (MTOR) delivered earnings and revenue surprises of 37.04% and -2.11%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Recap: Meritor Q2 Earnings

11:25am, Thursday, 30'th Apr 2020
Shares of Meritor (NYSE:MTOR) rose around 3% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share fell 28.16% over the past year to $0.74, which beat the es
Meritor sees Q3 revenue $400M-$500M, consensus $734.9M MTOR
Meritor reports Q2 adj. EPS 74c, consensus 46c MTOR
Meritor announces actions in response to COVID-19 pandemic MTOR

Meritor: Fiscal 2Q Earnings Snapshot

10:54am, Thursday, 30'th Apr 2020
TROY, Mich. (AP) _ Meritor Inc. (MTOR) on Thursday reported fiscal second-quarter profit of $240 million. The Troy, Michigan-based company said it had net income of $3.20 per share. Earnings, adjusted

Meritor: Fiscal 2Q Earnings Snapshot

10:53am, Thursday, 30'th Apr 2020
TROY, Mich. (AP) _ Meritor Inc. (MTOR) on Thursday reported fiscal second-quarter profit of $240 million. The Troy, Michigan-based company said it had net income of $3.20 per share. Earnings, adjusted
Meritor, Inc. (NYSE: MTOR) today reported financial results for its second fiscal quarter that ended March 31, 2020.

Meritor (MTOR) Q2 Earnings Top Estimates

12:00am, Thursday, 30'th Apr 2020

Meritor Q2 2020 Earnings Preview

09:30pm, Wednesday, 29'th Apr 2020
Meritor (NYSE:MTOR) is scheduled to announce Q2 earnings results on Thursday, April 30th, before market open.The consensus EPS Estimate is $0.39 (-62.1% Y/Y) and the consensus Revenue Estimate is $827
Findings Support Plans to Expand Clinical Evaluation of RMC-4630, the Company’s Investigational SHP2 Inhibitor, to Include Combination with Anti-PD-1 Drug
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE